strong rais qtr
buy rate reect view see bia upsid number
next month enough posit newsow clinic market
keep investor enthus total address market opportun
nextgen sequenc result rais sale
growth adjust ep guidanc stronger novaseq demand support
thing like
better novaseq util drive sale growth guidanc rais
rais full year sale growth guidanc
previou guidanc rang reect better-than-expect
stronger outlook sequenc consum growth led primarili
increas novaseq util compani also rais fy
adjust ep guidanc rang
mid-point upward guidanc revis reect stronger sale
growth outlook lower eectiv tax rate full year
strong sequenc consum growth driven novaseq util
sequenc consum grew y/i includ
stock order sever china custom ahead tari
implement growth exclud stock order still impress
still came well growth forecast manag
also note novaseq util hit new high nextseq product
famili also outperform post y/i growth consum
pull-through exceed high end
strength veriseq nipt sale well demand custom
translat research oncolog research clinic oncolog
hiseq consum thought datapoint especi
encourag directli address one challeng model
balanc net novaseq consum increas
grew y/i continu demand genom england project
continu ramp sampl process manag also
price jul usd
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar rm may conict interest could aect object report investor consid
report singl factor make invest decis disclosur analyst certif
note contribut non-invas prenat test nipt rare
undiagnos genet diseas rugd test servic
broad geograph health china emea continu standout
report robust growth across major geograph region
china outperform shipment growth exclud
stock order china still report record shipment growth
emea sale grew strong contribut genom england
program sale america grew
thing cautiou
china demand may lumpi though fundament remain strong
china sale growth impress aid
stock order sever custom advanc tari
implement fundament china remain healthi
anticip -china tari advers impact demand trend
believ growth may lumpi larg custom adopt
bulk order pattern said manag note exclud
stock order china report record shipment
rais pt
new pt reect enterpris valu use project level
debt cash ttm revenu forecast
roll valuat framework forward month previous reect
multipl ttm revenu forecast
forecast ratio
period end expens net incom attribut non-control incom attribut dilut share share alreadi ex amort cash flowoper cash cash ep incl
period end asset equival st receiv expens current current equip intang asset asset liabil account portion long-term current debt less current long-term liabil stockhold juli
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur
primari subject research pleas see recent publish compani report visit global disclosur look-up page websit http //research db com/
research/disclosures/companysearch asid within report import risk conict disclosur also found http //research db com/research/topics/equ
investor strongli encourag review inform invest
import disclosur requir regul
